About DNA polymerase epsilon subunit 2
DNA polymerase epsilon subunit 2 (POLE2) is a protein
from Homo sapiens identified by UniProt accession
P56282, 527 residues long.
MolForge cross-references it against 0 known binders and
338 disease associations.
Target properties
| Protein name | DNA polymerase epsilon subunit 2 |
| UniProt accession | P56282 |
| Gene | POLE2 |
| Organism | Homo sapiens |
| Length | 527 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (338)
Diseases linked to this target (Open Targets).
- non-small cell lung carcinoma · score 0.60
- acute myeloid leukemia · score 0.60
- acute lymphoblastic leukemia · score 0.60
- ovarian cancer · score 0.60
- pancreatic carcinoma · score 0.59
- chronic lymphocytic leukemia · score 0.59
- ovarian carcinoma · score 0.57
- breast carcinoma · score 0.57
- neoplasm · score 0.57
- adult acute lymphoblastic leukemia · score 0.56
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P56282-F1 | alphafold | PREDICTED | 92.98 | — |
Amino-acid sequence (527 residues)
MAPERLRSRA LSAFKLRGLL LRGEAIKYLT EALQSISELE LEDKLEKIIN AVEKQPLSSN MIERSVVEAA VQECSQSVDE TIEHVFNIIG AFDIPRFVYN SERKKFLPLL MTNHPAPNLF GTPRDKAEMF RERYTILHQR THRHELFTPP VIGSHPDESG SKFQLKTIET LLGSTTKIGD AIVLGMITQL KEGKFFLEDP TGTVQLDLSK AQFHSGLYTE ACFVLAEGWF EDQVFHVNAF GFPPTEPSST TRAYYGNINF FGGPSNTSVK TSAKLKQLEE ENKDAMFVFL SDVWLDQVEV LEKLRIMFAG YSPAPPTCFI LCGNFSSAPY GKNQVQALKD SLKTLADIIC EYPDIHQSSR FVFVPGPEDP GFGSILPRPP LAESITNEFR QRVPFSVFTT NPCRIQYCTQ EITVFREDLV NKMCRNCVRF PSSNLAIPNH FVKTILSQGH LTPLPLYVCP VYWAYDYALR VYPVPDLLVI ADKYDPFTTT NTECLCINPG SFPRSGFSFK VFYPSNKTVE DSKLQGF
Explore DNA polymerase epsilon subunit 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets